A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis

A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan (Rising Up): An interim 24-week analysis

Systemic atopic dermatitis treatments that have acceptable safety are needed.To evaluate the safety of the oral Janus kinase inhibitor upadacitinib in combination with topical corticosteroids (TCSs) for the treatment of atopic dermatitis.In this phase 3, double-blind study (Rising Up), Japanese pati...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Norito Katoh, Yukihiro Ohya, Hiroyuki Murota, Masanori Ikeda, Xiaofei Hu, Kimitoshi Ikeda, John Liu, Takuya Sasaki, Alvina D. Chu, Henrique D. Teixeira, Hidehisa Saeki
Materiálatiipa: Artigo
Giella:eaŋgalasgiella
Almmustuhtton: 2021
Liŋkkat:https://doi.org/10.1016/j.jdin.2021.11.001
http://www.jaadinternational.org/article/S2666328721000894/pdf
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Interneahtta

https://doi.org/10.1016/j.jdin.2021.11.001
http://www.jaadinternational.org/article/S2666328721000894/pdf

Geahča maid